Steve Jobs' Liver Transplant Performed at Memphis Hospital, Was Sickest Patient on Waiting List

Steve Jobs' liver transplant was performed at Methodist University Hospital in Memphis, TN. Here is a statement from the hospital:

James D. Eason, M.D., program director at Methodist University Hospital Transplant Institute and chief of transplantation confirmed today, with the patient's permission, that Steve Jobs received a liver transplant at Methodist University Hospital Transplant Institute in partnership with the University of Tennessee in Memphis. 

Mr. Jobs underwent a complete transplant evaluation and was listed for transplantation for an approved indication in accordance with the Transplant Institute policies and United Network for Organ Sharing (UNOS) policies. 

He received a liver transplant because he was the patient with the highest MELD score (Model for End-Stage Liver Disease) of his blood type and, therefore, the sickest patient on the waiting list at the time a donor organ became available. Mr. Jobs is now recovering well and has an excellent prognosis.

The Methodist University Hospital Transplant Institute performed 120 liver transplants in 2008 making it one of the ten largest liver transplant centers in the United States. We provide transplants to patients regardless of race, sex, age, financial status, or place of residence. Our one year patient and graft survival rates are among the best in the nation and were a dominant reason in Mr. Jobs’s choice of transplant centers. We respect and protect every patient's private health information and cannot reveal any further information on the specifics of Mr. Jobs's case.

Posted: June 23, 2009   For more information please contact: Ruth Ann Hale
http://www.methodisthealth.org/methodist/About+Us/Newsroom/News/Steve+Jobs+Receives+Liver+Transplant 

The MELD score (Model for End-Stage Liver Disease)

Resounding
Health
MELD Score

 

What did you think of this article?




Trackbacks
  • No trackbacks exist for this entry.
Comments
  • No comments exist for this entry.
Leave a comment

Submitted comments will be subject to moderation before being displayed.

 Enter the above security code (required)

 Name

 Email (will not be published)

 Website

Your comment is 0 characters limited to 3000 characters.